Factors associated with self-reported avoidance of harm reduction services during the COVID-19 pandemic by people who use drugs in five cities in the United States and Canada
- PMID: 35779987
- PMCID: PMC9225925
- DOI: 10.1016/j.drugalcdep.2022.109544
Factors associated with self-reported avoidance of harm reduction services during the COVID-19 pandemic by people who use drugs in five cities in the United States and Canada
Abstract
Background: This study examines individual-level factors associated with avoiding two important health services for people who use drugs-medications for treatment of opioid use disorder and syringe service programs-during the first year of the COVID-19 pandemic.
Methods: Data come from two subsamples of people who use drugs who were active participants in one of nine cohort studies in Vancouver, British Columbia; Baltimore, Maryland; Los Angeles, California; Chicago, Illinois; and Miami, Florida. Participants were interviewed remotely about COVID-19-associated disruptions to healthcare. We estimated the association of demographic, social, and health factors with each outcome using logistic regression among 702 participants (medication analysis) and 304 participants (syringe service analysis.) Analyses were repeated, stratified by city of residence, to examine geographic variation in risk.
Results: There were large differences between cities in the prevalence of avoiding picking up medications for opioid use disorder, with almost no avoidance in Vancouver (3%) and nearly universal avoidance in Los Angeles, Chicago, and Miami (>90%). After accounting for between-city differences, no individual factors were associated with avoiding picking up medications. The only factor significantly associated with avoiding syringe service programs was higher levels of self-reported worry about COVID-19.
Conclusion: During the first year of the COVID-19 pandemic, geographic differences in service and policy contexts likely influenced avoidance of health and harm reduction services by people who use drugs in the United States and Canada more than individual differences between people.
Keywords: COVID-19; Harm reduction, injection drug use; Methadone.
Copyright © 2022 Elsevier B.V. All rights reserved.
Conflict of interest statement
Conflicts of interest Dr. Milloy holds the Canopy Growth professorship in cannabis science at the University of British Columbia, a position established through arm’s length gifts to the university from Canopy Growth, a licensed producer of cannabis, and the Government of British Columbia’s Ministry of Mental Health and Addictions. He has no financial relationships with the cannabis industry.
Similar articles
-
Day-to-day impact of COVID-19 and other factors associated with risk of nonfatal overdose among people who use unregulated drugs in five cities in the United States and Canada.Drug Alcohol Depend. 2022 Dec 1;241:109633. doi: 10.1016/j.drugalcdep.2022.109633. Epub 2022 Sep 15. Drug Alcohol Depend. 2022. PMID: 36171158 Free PMC article.
-
Perceptions of access to harm reduction services during the COVID-19 pandemic among people who inject drugs in metropolitan Chicago.PLoS One. 2025 Jan 7;20(1):e0293238. doi: 10.1371/journal.pone.0293238. eCollection 2025. PLoS One. 2025. PMID: 39774394 Free PMC article.
-
Intersecting substance use treatment and harm reduction services: exploring the characteristics and service needs of a community-based sample of people who use drugs.Harm Reduct J. 2022 Aug 24;19(1):95. doi: 10.1186/s12954-022-00676-8. Harm Reduct J. 2022. PMID: 36002850 Free PMC article.
-
Health service utilisation and access for people who inject drugs during COVID-19.Drug Alcohol Rev. 2022 Sep;41(6):1304-1310. doi: 10.1111/dar.13456. Epub 2022 Mar 9. Drug Alcohol Rev. 2022. PMID: 35266229 Free PMC article. Review.
-
Rapid evidence review of harm reduction interventions and messaging for people who inject drugs during pandemic events: implications for the ongoing COVID-19 response.Harm Reduct J. 2020 Dec 1;17(1):95. doi: 10.1186/s12954-020-00445-5. Harm Reduct J. 2020. PMID: 33261636 Free PMC article. Review.
Cited by
-
Modeling the impact of the COVID-19 pandemic on achieving HCV elimination amongst young and unstably housed people who inject drugs in San Francisco.Int J Drug Policy. 2024 Sep;131:104452. doi: 10.1016/j.drugpo.2024.104452. Epub 2024 Jun 22. Int J Drug Policy. 2024. PMID: 38910096 Free PMC article.
-
Enumerating contributions of fentanyls and other factors to the unprecedented 2020 rise in opioid overdose deaths: model-based analysis.PNAS Nexus. 2023 Mar 3;2(4):pgad064. doi: 10.1093/pnasnexus/pgad064. eCollection 2023 Apr. PNAS Nexus. 2023. PMID: 37020497 Free PMC article.
-
Impact of Pandemic-Induced Service Disruptions and Behavioral Changes on Hepatitis C Virus and HIV Transmission Amongst People Who Inject Drugs: A Modeling Study.J Infect Dis. 2025 Mar 17;231(3):633-642. doi: 10.1093/infdis/jiae599. J Infect Dis. 2025. PMID: 39657251
-
Trends in self-reported non-fatal overdose and patterns of substance use before and during the COVID-19 pandemic in a prospective cohort of adults who have injected drugs - Baltimore, Maryland, 2014-2022.Drug Alcohol Depend. 2023 Oct 1;251:110954. doi: 10.1016/j.drugalcdep.2023.110954. Epub 2023 Sep 4. Drug Alcohol Depend. 2023. PMID: 37716287 Free PMC article.
-
A Scoping Review on the Effects of COVID-19 on Syringe Service Programs in the United States.Cureus. 2023 May 15;15(5):e39023. doi: 10.7759/cureus.39023. eCollection 2023 May. Cureus. 2023. PMID: 37378253 Free PMC article.
References
-
- Aspinall E.J., Nambiar D., Goldberg D.J., Hickman M., Weir A., Van Velzen E., Palmateer N., Doyle J.S., Hellard M.E., Hutchinson S.J. Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis. Int. J. Epidemiol. 2014;43:235–248. doi: 10.1093/ije/dyt243. - DOI - PubMed
-
- Auger K.A., Shah S.S., Richardson T., Hartley D., Hall M., Warniment A., Timmons K., Bosse D., Ferris S.A., Brady P.W., Schondelmeyer A.C., Thomson J.E. Association between statewide school closure and COVID-19 incidence and mortality in the US. JAMA. 2020;324:859–870. doi: 10.1001/jama.2020.14348. - DOI - PMC - PubMed
-
- B.C. COVID-19 Dashboard [WWW Document], n.d. URL https://experience.arcgis.com/experience/a6f23959a8b14bfa989e3cda29297ded (accessed 8.5.21).